Rivaroxaban - Wikipedia

Rivaroxaban è un inibitore diretto e molto selettivo del fattore Xa. L'inibizione del fattore Xa causata dalla molecola blocca contemporaneamente la via intrinseca e ...

Rivaroxaban Uses, Side Effects & Warnings - Drugs.com

Physician reviewed rivaroxaban patient information - includes rivaroxaban description, dosage and directions.

Rivaroxaban - Wikipedia

Rivaroxaban is een antistollingsmiddel dat ingrijpt in de bloedstolling door het reversibel remmen van factor Xa. In tegenstelling tot de klassieke anticoagulantia ...

Rivaroxaban — Wikipédia

Le rivaroxaban est un médicament anticoagulant oral direct, inhibiteur du facteur Xa de la famille des oxazolidinones. Il est commercialisé en France sous le nom de ...

Rivaroxaban – Wikipedia

Pharmakologische Eigenschaften. Es handelt sich um eine Substanz aus der Gruppe der Oxazolidinone. Rivaroxaban wird enteral resorbiert und unterliegt einem First-Pass ...

XARELTO® (rivaroxaban)

XARELTO ®, in combination with low-dose aspirin (75 mg–100 mg), is now approved for people with chronic coronary artery disease (CAD) or peripheral artery disease ...

rivaroxaban (Xarelto): Drug Facts, Side Effects, and Dosing

Consumer information about rivaroxaban (Xarelto), a drug prescribed to prevent or treat AFib, DVT, and pulmonary embolism. Side effects, drug interactions, dosing ...

Rivaroxaban | C19H18ClN3O5S - PubChem - The PubChem Project

Rivaroxaban is an orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Xa with anticoagulant activity. Upon oral administration ...

Rivaroxaban - Wikipedia

Rivaroxaban, sold under the brand name Xarelto, among others, is an oral anticoagulant medication (blood thinner). It is commonly used to prevent blood clots.

Oral Rivaroxaban for Symptomatic Venous Thromboembolism | NEJM

Background Rivaroxaban, an oral factor Xa inhibitor, may provide a simple, fixed-dose regimen for treating acute deep-vein thrombosis (DVT) and for continued ...